BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that effective March 24, 2006, its Board of Directors had appointed PricewaterhouseCoopers LLP, Chartered Accountants (“Pricewaterhouse”) as the Company’s new independent auditors, replacing the firm of Collins Barrow, Chartered Accountants (“Collins Barrow”).
